Long-Term predictive value of cyclosporine microemulsion C2 level for chronic renal allograft dysfunction
- 1 December 2003
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 35 (8) , 2894-2898
- https://doi.org/10.1016/j.transproceed.2003.10.012
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Clinical benefits of neoral C2 monitoring in the long-term management of renal transplant recipients1Transplantation, 2003
- Cyclosporine Microemulsion (Neoral®) Absorption Profiling and Sparse-sample Predictors During the First 3 Months after Renal TransplantationAmerican Journal of Transplantation, 2002
- Monitoring of CYA C2 levels is predictive for AUC in lung transplant recipientsThe Journal of Heart and Lung Transplantation, 2002
- ABSORPTION PROFILING OF CYCLOSPORINE MICROEMULSION (NEORAL) DURING THE FIRST 2 WEEKS AFTER RENAL TRANSPLANTATION1Transplantation, 2001
- ABSORPTION PROFILING OF CYCLOSPORINE THERAPY FOR DE NOVO KIDNEY TRANSPLANTATION: A PROSPECTIVE, RANDOMIZED STUDY COMPARING SPARSE SAMPLING TO TROUGH MONITORING.Transplantation, 2000
- Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996New England Journal of Medicine, 2000
- NEORAL MONITORING BY SIMPLIFIED SPARSE SAMPLING AREA UNDER THE CONCENTRATION-TIME CURVETransplantation, 1999
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999
- COMPARISON OF NEORAL DOSE MONITORING WITH CYCLOSPORINE TROUGH LEVELS VERSUS 2-HR POSTDOSE LEVELS IN STABLE LIVER TRANSPLANT PATIENTS1,2Transplantation, 1998
- Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantationClinical Pharmacology & Therapeutics, 1993